3 results match your criteria: "Hospital General Universitario San Jorge de Huesca[Affiliation]"

SEA 2024 Standards for Global Control of Vascular Risk.

Clin Investig Arterioscler

May 2024

Servicio de Bioquímica Clínica, Unidad de Lípidos, Hospital General Universitario San Jorge de Huesca, Huesca, España; Departamento de Medicina, Universidad de Zaragoza, Zaragoza, España.

One of the objectives of the Spanish Society of Arteriosclerosis is to contribute to the knowledge, prevention and treatment of vascular diseases, which are the leading cause of death in Spain and entail a high degree of disability and health expenditure. Atherosclerosis is a multifactorial disease and its prevention requires a global approach that takes into account the associated risk factors. This document summarises the current evidence and includes recommendations for patients with established vascular disease or at high vascular risk: it reviews the symptoms and signs to evaluate, the laboratory and imaging procedures to request routinely or in special situations, and includes the estimation of vascular risk, diagnostic criteria for entities that are vascular risk factors, and general and specific recommendations for their treatment.

View Article and Find Full Text PDF
Article Synopsis
  • * The use of statins, which are standard treatments for FH, can lead to muscular symptoms in some patients, highlighting the need for better understanding of individual responses.
  • * The study emphasizes the role of mitochondrial genetic variations, particularly CoQ, as potential markers for FH progression and statin-related side effects, aiming for personalized treatment strategies.
View Article and Find Full Text PDF

SEA 2022 Standards for Global Control of Cardiovascular Risk.

Clin Investig Arterioscler

June 2022

Servicio de Endocrinología y Nutrición, Área de Atención Integrada de Riesgo Vascular, Hospital Sant Joan Despí-Moisès Broggi, Sant Joan Despí, Barcelona, España.

One of the objectives of the Spanish Society of Arteriosclerosis is to contribute to better knowledge of vascular disease, its prevention and treatment. It is well known that cardiovascular diseases are the leading cause of death in our country and entail a high degree of disability and health care costs. Arteriosclerosis is a multifactorial disease and therefore its prevention requires a global approach that takes into account the different risk factors with which it is associated.

View Article and Find Full Text PDF